# A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)

> **NCT00002170** · PHASE2 · COMPLETED · sponsor: **Agouron Pharmaceuticals**

## Conditions studied

- Mycobacterium Avium-Intracellulare Infection
- HIV Infections

## Interventions

- **DRUG:** Nelfinavir mesylate

## Key facts

- **NCT ID:** NCT00002170
- **Lead sponsor:** Agouron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002170, "A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00002170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*